about
Characterization and prediction of the mechanism of action of antibiotics through NMR metabolomics.The Effectiveness and Safety of a Homeopathic Medicinal Product in Pediatric Upper Respiratory Tract Infections With Fever: A Randomized Controlled TrialUnconventional screening approaches for antibiotic discovery.Antibiotics Clinical Development and Pipeline.Past, Present, and Future of Antibacterial Economics: Increasing Bacterial Resistance, Limited Antibiotic Pipeline, and Societal Implications.Improving Conduct and Feasibility of Clinical Trials to Evaluate Antibacterial Drugs to Treat Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia: Recommendations of the Clinical Trials Transformation Initiative AntibThe antibiotic pipeline: reviving research and development and speeding drugs to market.Agricultural Applications for Antimicrobials. A Danger to Human Health: An Official Position Statement of the Society of Infectious Diseases Pharmacists.Resistance in antimicrobial photodynamic inactivation of bacteria.Combination therapy with polymyxin B and netropsin against clinical isolates of multidrug-resistant Acinetobacter baumannii.Phenotypic and genotypic characterization of antimicrobial susceptibility of avian pathogenic Escherichia coli isolated from broiler chickens.Pyruvate cycle increases aminoglycoside efficacy and provides respiratory energy in bacteria.Resensitization of methicillin-resistant Staphylococcus aureus by amoxapine, an FDA-approved antidepressant.Mugs of the bugs: The most wanted ones.Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next steps.Attaching NorA efflux pump inhibitors to methylene blue enhances antimicrobial photodynamic inactivation of Escherichia coli and Acinetobacter baumannii in vitro and in vivo.Comparative genomics reveals phylogenetic distribution patterns of secondary metabolites in Amycolatopsis species.Hybridization and antibiotic synergism as a tool for reducing the cytotoxicity of antimicrobial peptides.
P2860
Q36012460-17ACF75E-980B-47B2-AA7C-E7C8B1AFE681Q37123643-5F1C264C-B76B-4052-B346-6457199F9C44Q38534653-94B0AFBB-5FE4-474D-A634-0A817B21BAC0Q38544966-9E890638-3FE2-4911-96E4-4EA86627D145Q38793981-AE59D97E-7504-4C8A-8191-A06192264346Q38915822-2A7F083D-C222-459A-8595-6C2C91CEB00EQ40290086-3F8B3FE2-327A-4EB9-9793-58BFAC9D0E18Q40763425-7B3B9EA3-0248-46DA-97C7-F1FA6E667832Q41146823-6C36910A-5DB6-4FF3-8E62-CB5527F477D6Q42701999-4CFF58C6-DB00-44E8-8D2B-0288280BD166Q47143387-5F405F27-A9A7-4129-AC38-8D158DA1F562Q47643503-EAEE4540-4F9F-4563-AAE4-8D8CE858AD2CQ47651919-A7B30CFF-E3F9-4EDD-85C3-6F0CD19DC795Q48271598-6DB6A5CE-667B-4619-B97E-6BC64EB23AD4Q48564199-F1FB30F7-463F-4EE8-A512-517C02917134Q52665872-CCEB7802-BA4B-4B96-94BF-B22F4C470FF7Q54976928-421DBCCB-C748-46D3-BE64-A84656FAFAD8Q55439082-0D634DD5-86BE-4AE4-A952-7A5C082AFBE4
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The future of antibiotics
@ast
The future of antibiotics
@en
type
label
The future of antibiotics
@ast
The future of antibiotics
@en
prefLabel
The future of antibiotics
@ast
The future of antibiotics
@en
P2860
P356
P1433
P1476
The future of antibiotics
@en
P2093
Brad Spellberg
P2860
P2888
P356
10.1186/CC13948
P577
2014-06-27T00:00:00Z
P5875
P6179
1024098143